Covaxin safe, immunogenic with no side effects, says Lancet : Bulletin: Business Today
Business Today

Covaxin safe, immunogenic with no side effects, says Lancet

Loading the player...

Rashi Bisaria | March 10, 2021

Covaxin safe, immunogenic with no side effects, says Lancet

Medical peer-review journal Lancet has published the interim results for phase 2 trials of Bharat Biotech's COVID-19 vaccine, Covaxin, calling it 'safe, immunogenic with no serious side effects'. The double-blind, randomised, multicentre, phase 2 clinical trial to evaluate the immunogenicity and safety of Covaxin (BBV152) in healthy adults and adolescents (aged 12-65 years) was carried out at nine hospitals in India.

Data breach can put up to $223 billion value of top-100 global brands at risk: Infosys

Data breach could put at risk up to $223 billion of brand value of the top 100 brands of the world, as per a joint cybersecurity and brand value impact report by Infosys and global brand consultancy firm Interbrand. The report examined the long-term impact of data breaches on value of the world's top brands across sectors.

Tesla surges almost 20%, biggest daily rise in a year

Shares of electric vehicle maker Tesla Inc surged nearly 20% on Tuesday, rebounding from a deep selloff with its largest daily gain in a year after data showed an increase in China sales and an analyst raised his rating on the stock. The jump, which added over $100 billion to Tesla's market capitalization, stopped a five-day streak of losses for the company in a Nasdaq slump in which investors spooked by rising interest rates have abandoned growth stocks with heady valuations. Tesla's stock remains up about 70% over the past six months.

Delhi to convert entire transport system to electric: Manish Sisodia

The Delhi government aims to convert its entire transport fleet to an electric vehicle system in the next 25 years, Deputy Chief Minister Manish Sisodia said on Tuesday.It is an aspirational dream to convert the entire transport system of Delhi to electric in the next 25 years but it is not impossible, Sisodia added.

Mahindra fires 300 executives as slowdown stings

In a major restructuring move, homegrown auto major Mahindra & Mahindra has fired around 300 management executives since the start of this calendar year as the slowdown in the domestic automotive industry exacerbated, with the pandemic taking its toll. The automotive division of Mahindra, which suffered the brunt of the layoffs, has suffered a debilitating 27.52 per cent decline in sales in this fiscal so far. Industry volumes have shrunk by 13.2 per cent.

US to ship 18.5 million COVID-19 vaccine doses this week: White House

The White House said on Tuesday that the government will distribute around 18.5 million doses of COVID-19 vaccines this week, fewer than last week because no new doses of Johnson & Johnson's vaccine are ready to be sent out. J&J's manufacturing has been slower than expected, and the company was not expected to be able to deliver any doses of its vaccine this week

More from this section